Gossamer Bio GOSS Income Statement (2018-2026)

NASDAQ GOSS
$11.58 +0.06 (+0.52%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Gossamer Bio Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

Gossamer Bio reported revenue of $9.24M and net income of -$28.51M for the quarter ended Jun 2026, down 19.6% year over year. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
95.84M9.48M9.38M9.89M11.49M13.29M13.80M16.95M9.24M
Operating items
Research & DevelopmentR&D
43.19M40.93M42.32M42.58M44.51M41.51M37.80M36.31M31.20M29.97M32.39M35.09M34.90M36.11M38.04M41.58M45.54M48.94M43.08M26.41M
Share-based Compensation (IS)Stock Comp.
7.59M7.66M10.98M10.00M10.12M11.45M8.13M8.20M6.16M6.03M5.81M
Selling, General & AdministrativeSG&A
12.46M10.71M12.00M11.28M11.50M12.83M10.13M9.98M9.29M9.06M9.57M8.67M8.50M9.39M8.66M8.68M9.39M10.90M18.75M8.90M
Other Operating ExpensesOther Opex
0.01M0.01M0.02M0.01M0.01M0.01M0.01M0.01M10.00M7.48M-0.00M
Operating ExpensesOpex
55.66M51.66M54.34M53.87M56.02M54.36M47.94M46.30M40.49M49.03M41.96M43.76M43.40M45.51M46.70M50.25M62.41M59.84M61.82M35.31M
Operating IncomeOp. Inc
-55.66M-51.66M-54.34M-53.87M-56.02M-54.36M-47.94M-46.30M-40.49M-49.03M-41.96M52.09M-33.92M-36.13M-36.81M-38.77M-49.11M-46.04M-44.87M-26.07M
EBIT
-55.66M-51.66M-54.34M-53.87M-56.02M-54.36M-47.94M-46.30M-40.49M-49.03M-41.96M52.09M-33.92M-36.13M-36.81M-38.77M-49.11M-46.04M-44.87M-26.07M
Non-operating items
Non Operating Interest Expenses
4.89M4.94M3.47M3.48M3.48M3.46M3.50M3.43M3.34M3.24M3.13M2.92M2.73M2.74M2.75M2.74M2.75M2.75M2.75M2.71M
Interest & Investment IncomeInt & Inv Inc
0.19M0.24M0.22M0.30M0.47M0.59M0.59M0.69M0.41M0.31M0.34M1.75M0.43M-0.74M0.29M0.54M0.69M0.45M0.35M0.27M
Other Non Operating IncomeOther Non Op Inc.
0.12M0.08M-0.20M0.59M-0.33M1.46M1.69M6.54M3.42M3.81M2.82M2.75M4.29M4.17M2.62M2.69M2.95M1.02M0.60M43.85M
Non Operating IncomeNon Op. Inc.
-4.58M-4.62M-3.44M-2.59M-3.34M-1.41M-1.22M3.80M0.48M0.88M0.03M1.58M1.98M0.69M0.17M0.49M0.89M-1.29M-1.80M42.97M
Net income details
EBT
-60.36M-56.36M-57.59M-57.05M-59.03M-57.22M-50.85M-42.50M-40.01M-48.15M-44.74M53.67M-31.93M-35.44M-39.26M-38.27M-48.22M-47.33M-47.27M-28.51M
Tax ProvisionsTaxes
4.43M-1.13M-2.41M-0.09M
Profit After TaxPAT
-60.36M-56.36M-57.59M-57.05M-59.03M-57.22M-50.85M-42.50M-40.01M-48.15M-44.74M49.23M-30.80M-33.03M-39.26M-38.27M-48.22M-47.24M-47.27M-28.51M
Income from Continuing OperationsIncome (Continuing)
-60.36M-56.36M-57.59M-57.05M-59.03M-57.22M-50.85M-42.50M-40.01M-48.15M-44.74M49.23M-30.80M-33.03M-39.26M-38.27M-48.22M-47.24M-47.27M-28.51M
Consolidated Net IncomeConsol Net Inc.
-60.36M-56.36M-57.59M-57.05M-59.03M-57.22M-50.85M-42.50M-40.01M-48.15M-44.74M49.23M-30.80M-33.03M-39.26M-38.27M-48.22M-47.24M-47.27M-28.51M
Income towards Parent CompanyParent Net Inc
-60.25M-56.28M-57.78M-56.47M-59.36M-55.76M-49.16M-42.50M-40.01M-48.15M-41.93M49.23M-30.80M-33.03M-36.64M-38.27M-48.22M-47.24M-46.66M16.90M
Net Income towards Common StockholdersNet Income
-60.25M-56.28M-57.78M-56.47M-59.36M-55.76M-49.16M-42.50M-40.01M-48.15M-41.93M49.23M-30.80M-33.03M-36.64M-38.27M-48.22M-47.24M-46.66M16.90M
Additional items
EPS (Basic)
-64.26-60.16-60.91-58.92-52.08-52.75-41.46-35.62-16.59-25.24-14.8617.41-10.89-11.68-12.92-13.47-16.92-16.54-15.944.22
EPS (Diluted)
-64.26-60.16-60.91-58.92-52.08-52.75-41.46-35.62-16.59-25.24-14.8616.51-10.89-11.68-12.92-13.47-16.92-16.54-15.944.11
Shares Outstanding
0.94M0.94M0.95M0.96M1.14M1.06M1.19M1.19M2.41M1.91M2.82M2.83M2.83M2.83M2.84M2.84M2.85M2.86M2.93M4.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.94M0.94M0.95M0.96M1.14M1.06M1.19M1.19M2.41M1.91M2.82M2.98M2.83M2.83M2.84M2.84M2.85M2.86M2.93M4.11M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.94M0.95M0.96M0.96M1.17M1.18M1.19M1.19M2.82M1.91M2.83M2.83M2.83M2.83M2.84M2.84M2.89M2.92M2.93M4.00M
EBITDA
-55.16M-51.22M-53.84M-53.37M-55.52M-53.92M-47.44M-45.80M-40.09M-48.73M-41.70M52.39M-33.72M-36.02M-36.80M-38.76M-49.11M-46.03M-44.86M
Interest ExpensesInt Expense
4.89M4.94M3.47M3.48M3.48M3.46M3.50M3.43M3.34M3.24M3.13M2.92M2.73M2.74M2.75M2.74M2.75M2.75M2.75M2.71M
Tax Rate
8.26%

Gossamer Bio Income Statement API

Pull Gossamer Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GOSS&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY